Regulatory Updates
🇪🇺 EMA Page 14EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 157–168 of 171 articles
MHRA Post-Brexit Drug Approval: Key Divergences from EMA in Oncology
MHRA post-Brexit regulatory pathways: What You Need to Know
Brand Institute Receives First EMA Approval for AI-Developed Pharmaceutical Brand Name Using Brandi Platform
PRAC Guidelines Liver Injury: What You Need to Know
AI Drug Discovery EU: Accelerating Rare Disease Therapies via COMP & EMA
European Commission Blockchain Pilot Enhances Pharmaceutical Supply Chain Security
AI in European Pharmaceutical R&D: Investment & Regulatory Insights
Gene Therapies for Neurological Disorders: EMA Approval Trends & Insights
EU Clinical Trials Regulation 2026: Impact on Rare Disease Drug Development
GDPR Impact on Pharmaceutical Data: What You Need to Know
AI-Powered Clinical Trial Matching: Transforming Patient Recruitment in the EU
Digital Therapeutics in Europe: Market Trends and EMA Regulatory Insights